News

FUJIFILM invests in VALANX Biotech to advance next generation therapeutics.

Factory planning has historically been constrained by time, manual effort, and limited iteration. Each layout represents...

From Science to Company Building

Autonomous systems must operate in environments that are complex, dynamic, and unpredictable. Testing these systems in...

XISTA Science Ventures portfolio company Vitrealab Closes $11 Million Series A to Accelerate Development of Quantum...

Augmented reality has long been constrained by hardware — particularly the light engine, where size, efficiency, and...

Turning scientific research into scalable companies remains one of the central bottlenecks in life sciences. The...

Rapid diagnostics have become a cornerstone of modern healthcare — accessible, fast, and scalable. Yet their limitations...

A significant portion of critical infrastructure lies underwater — yet remains difficult to inspect and monitor.

Most advanced AI models are designed for centralized infrastructure. But many applications — from vehicles to edge...

Strong life sciences investments require more than capital — they depend on deep scientific and industry expertise...

At xista, we are building while growing: Expanding our team, launching new ventures, forming strategic partnerships, and...

Syntropic Medical has announced the launch of a groundbreaking clinical study testing a new non-invasive brain...

ReCatalyst, a xista portfolio company pioneering next-generation nanocatalysts for the hydrogen economy, has announced...

Scientific breakthroughs are transforming industries at an unprecedented pace. Yet the key challenge remains: How do we...

xista science ventures is now part of the EIC Trusted Investors Network — joining over 100 leading investors to support...

With a commitment to innovation, xista is breaking new ground—literally. The beginning of the new year marks the start...

A fireside chat with Stephan Huber and Markus Wanko

On September 19th, the tranquil Campus of the Institute for Science and Technology Austria (ISTA) transformed into a...

xbio alumna Gunpreet Oberoi and her Safe Vascular Access Needle (SVAN) win 3D Printing Life Sciences Award, on top of...

With a varied program, xista and VERBUND X showed at Venture Day how the ecosystem in the cleantech sector can be...

Pre-clinical stage MedTech company Syntropic Medical, has secured a €1.1M grant from the Österreichische...

The 2024 Edition of bigX will explore the Future of AI. Get excited by the newest AI breakthroughs and applications...

As part of the "Innovation Corner" exhibition series, the xista portfolio companies Syntropic Medical and VALANX Biotech...

xbio Biotech Enterprise Masterclass celebrates it's second run! On Demo Day cohort 2024 pitched their innovations to 60+...

Securing €63 million in its Series B funding round, Prewave reaches the next milestone in it's remarkable growth journey...

Our Venture Partner, Bernhard Petermeier, was featured in Cleantech for Europe’s Voices of Innovation series commenting...

President of the European Commission Ursula von der Leyen visited the xista ecosystem on campus in Klosterneuburg on...

xista science ventures hosted it's much-anticipated “Investors and Portfolio Day” centered around the theme “Shaping...

MedTech company secures 7-figure early-stage funding from xista science ventures and Austria Wirtschaftsservice, to...